Vericel Expects Record MACI Sales to End 2021

By Mike Evers

Vericel Expects Record MACI Sales to End 2021
The company's MACI product declined in the low single digits for 3Q21 but Vericel expects a record-setting fourth quarter.

Member-Only Content

SUBSCRIBE Login

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Revenue Report